Oncology Institute (TOIIW) Assets (2019 - 2026)

Oncology Institute (TOIIW) has 8 years of Assets data on file, last reported at $168.2 million in Q1 2026.

• For the quarter ending Q1 2026, Assets rose 2.58% year-over-year to $168.2 million; the trailing twelve-month figure through Mar 2026 stood at $168.2 million (up 2.58% YoY), and the FY2025 full-year result was $164.7 million, down 4.67% from the prior year.
• Assets for Q1 2026 stood at $168.2 million, up from $164.7 million in the prior quarter.
• Across five years, Assets topped out at $283.8 million in Q3 2022 and bottomed at $159.8 million in Q2 2025.
• The 5-year median for Assets is $189.7 million (2022), against an average of $199.4 million.
• The widest annual swing landed in 2022, when Assets advanced 28.62%; it then slipped 23.06% in 2023.
• A 5-year view of Assets shows it stood at $261.7 million in 2022, then fell by 20.04% to $209.2 million in 2023, then dropped by 17.46% to $172.7 million in 2024, then decreased by 4.67% to $164.7 million in 2025, then rose by 2.17% to $168.2 million in 2026.
• The last three Assets figures came in at $168.2 million (Q1 2026), $164.7 million (Q4 2025), and $163.6 million (Q3 2025), per Business Quant data.

Peer Comparison